Navigation Links
CWRU grants Disease Diagnostic Group option on malaria diagnostic device
Date:7/30/2013

CLEVELANDCase Western Reserve University has granted a two-year technology transfer option to a research spinoff company developing a hand-held device that diagnoses malaria more quickly, simply and affordably than existing methods.

Disease Diagnostic Group LLC, the startup formed last summer from biomedical engineering research at the university's School of Engineering, also raised $250,000 to "field-test" the device this fall in Peru. These research dollars have come from various sources, including the Coulter Foundation. The Case Coulter Translation Research Partnership provides research dollars primary focused on clinical translation for medical devices.

The option from the university's Technology Transfer Office allows the company time to evaluate its Rapid Assessment of Malaria (RAM) device as an important pre-licensing step toward commercialization.

"They will be employing a working prototype to conduct field studies this fall to validate their design and ease of operation," said Wayne Hawthorne, the university's senior licensing manager. "There is a big push worldwide to eradicate infectious diseases, such as malaria."

DDG's product detects a magnetic substance that malaria parasites release when digesting red blood cells. RAM's creators can provide a faster and more accurate diagnostic test than methods now commonly used. The device is designed to detect the disease in less than a minute using a drop of blood from a patient's fingertip.

Brian Grimberg, assistant professor of international health and DDG's co-founder, president and chief medical officer, said early diagnosis is vital in reducing malaria deaths because early treatment is nearly 100 percent effective. However, half of the estimated 500 million annual infections worldwide go undiagnosed, according to the World Health Organization.

Potential RAM customers, including the U.S. military, could use the device in areas with limited medical access, often in remote, disease-prone areas, Grimberg said.

"We think we have an opportunity to make a difference in millions of lives," said Grimberg, part of Case Western Reserve School of Medicine's Center for Global Health and Diseases. "We may be able to license the technology in about a year. What we have to do is take this device into the field for point-of-care diagnosis. We have to show that it works, so that we can seek World Health Organization approval."

"This project is an excellent example of the way in which translational research at CWRU can make a difference in patient care," said Colin Drummond, director of the Coulter-Case Translational Research partnership within the Department of Biomedical Engineering. "It has taken years of hard work by Dr. Grimberg for this technology to reach the point where it was positioned to be translated into the market. It has been rewarding for the Coulter program to play a part in the translational phase of the project."

John R. Lewandowski, a recent Case Western Reserve engineering and management graduate, is DDG's co-founder and chief executive officer. His brother, Mark Lewandowski, a sophomore computer science and accounting student at the university, is DDG's chief financial officer.

The university's Technology Transfer Office, which supports faculty and student intellectual property and commercialization, has guided DDG to an innovation network, including such organizations as BioEnterprise and JumpStart.

Working with the Center for Global Health and Diseases and the Department of Infectious Diseases and HIV Medicine, Case Western Reserve is committed to licensing its medical discoveries, such as the RAM device, in ways that promote access and affordability in developing countries. As a result, the Universities Allied for Essential Medicines recently ranked Case Western Reserve the No. 1 Global Health research university in the United States.


'/>"/>

Contact: Marv Kropko
mrk107@case.edu
216-368-6890
Case Western Reserve University
Source:Eurekalert

Related biology news :

1. Scientist wins $3 million renewal of one of longest-running NIH grants to Scripps Research
2. Bay Area PV Consortium announces $7.5 million in grants to lower the cost of large-scale solar
3. Grants add to Northwestern-Qatar partnership
4. American Health Assistance Foundation announces grants to advance promising vision research
5. 6 NARSAD Young Investigator Grants awarded to CAMH
6. 2 UNC faculty receive Autism Centers of Excellence grants for new research
7. New NIH/NHGRI grants to harness nanoscale technologies to cut DNA sequencing costs
8. Columbia awarded 1 of first Provocative Questions grants from NCI
9. UNH labs receive 2 NSF grants totalling $1.35m for research instruments
10. FDA Grants Meridian Laboratories Pre-Ind Meeting for Captisol-Enabled Docetaxel in the Treatment of Cancer
11. Baylor University scientist receives major grants for health research on 1991 Gulf War veterans
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2017)... , March 2, 2017 Australian stem cell ... (ASX: CYP), has signed an agreement with the Monash ... Monash Biomedicine Discovery Institute and Department of Pharmacology at ... a further preclinical study to support the use of ... asthma.  Asthma is a chronic, long ...
(Date:2/28/2017)... LOS ANGELES , Feb. 28, 2017   ... identity verification software globally, announces significant enhancements to new ... in May 2016. New products include mobile and desktop ... and DocX TM - a real time manual ... Acuant,s core idScan® technology provides the fastest and most ...
(Date:2/28/2017)... , Spanien, 27. Februar 2017  EyeLock LLC, ein ... wird seine erstklassige biometrische Lösung zur Iris-Erkennung ... mit X16 LTE auf dem Mobile World ... am Qualcomm-Stand in Halle 3, Stand 3E10, ... die Sicherheitsplattform Qualcomm Haven™ – eine Kombination ...
Breaking Biology News(10 mins):
(Date:3/23/2017)... 2017  GlobeImmune, Inc. today announced it has entered ... 12,835,490 shares of its common stock to NantCell, Inc., ... with the sale of its common stock, NantCell has ... to GlobeImmune 200,000 shares, an estimated $2.0 million in ... are pleased to enter into this strategic agreement with ...
(Date:3/23/2017)... , March 23, 2017 NetworkNewsWire ... ... death, putting significant strain on health care systems, in terms ... diagnoses rises, so too does the development of innovative and ... side effects. Among the many types of cancer treatments, a ...
(Date:3/23/2017)... La. (PRWEB) , ... March 23, 2017 , ... ... industrial monitoring solutions, today announced the hire of Dr. Sigmund “Sig” Floyd as ... customer applications, strategic partnerships and joint development activities. , “Dr. Floyd’s career has ...
(Date:3/22/2017)... MONICA, Calif. , March 22, 2017 /PRNewswire/ ... are proud to announce their extended partnership and ... will be headlined by the 21 st ... BIOMEDevice Boston, taking place May 3-4, 2017. ... Advanced Medical Technology Association (ADVAMED) President and CEO, ...
Breaking Biology Technology: